Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury
Acute kidney injury (AKI) is a major contributor to in-hospital morbidity and mortality. Vancomycin, one of the most commonly used antibiotics in a clinical setting, is associated with AKI, with its incidence ranging up to 43%. Despite the high demand, few studies have investigated serum biomarkers...
Guardado en:
Autores principales: | Sang-Mi Kim, Hyun-Seung Lee, Min-Ji Kim, Hyung-Doo Park, Soo-Youn Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2338c5dd26f34f3b956c7b5a3e6004df |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older
por: Wang Y, et al.
Publicado: (2021) -
Role of Serum Uromodulin in the Early Diagnosis of Chronic Kidney Disease
por: Genov D., et al.
Publicado: (2021) -
Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality
por: Alshehri N, et al.
Publicado: (2020) -
<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia
por: Kateřina Bogdanová, et al.
Publicado: (2021) -
Ileostomía en asa derivativa y lavado colónico intraoperatorio como alternativa de tratamiento en un caso de colitis grave por Clostridium difficile
por: Quezada,Felipe, et al.
Publicado: (2015)